Skip to main content
Premium Trial:

Request an Annual Quote

Paul Billings

Biological Dynamics has appointed Paul Billings to its board of directors. Billings' addition increases board membership to four directors.

Billings currently serves as an executive-in-residence at Janssen Diagnostics, a division of Johnson & Johnson, and is the medical director of the IMPACT Cancer Care Program at Thermo Fisher Scientific. Previously, he has served on the scientific advisory board of the US Food and Drug Administration and the Genomic Medicine advisory committee at the Department of Veterans Affairs. Billings has also held academic appointments at Harvard University, the University of California San Francisco, Stanford University, and UC Berkeley; has served as a physician at a number of leading medical centers; and served as chief medical officer of Life Technologies and the genetic sciences division of Thermo Fisher Scientific.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.